Hidradenitis Suppurativa Research Study (52 Weeks)

Men and women aged 18 years or older with moderate to severe hidradenitis suppurativa (HS) for at least 1 year, may qualify to participate in this study. Individuals must have lesions present in at least 2 distinct anatomical areas. Stable HS for at least 1 month prior to the screening visit, will be determined by the study doctor.

Eligible participants will receive investigational medication (active drug) and/or placebo via injection. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 52 weeks and include about 15 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Hidradenitis Suppurativa
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more